Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
D000433:1-Propanol / Q000627:therapeutic use*; D000083:Acetanilides / Q000009:adverse effects / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D010919:Placebos; D011433:Propranolol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use*; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D010919:Placebos; D011437:Propylamines; D013565:Sympatholytics; D000433:1-Propanol; D011433:Propranolol